Micro Labs Gmbh Pharmaceutical Import Profile — Belgium (DGFT 2022–2026)

Name: Micro Labs Gmbh Pharmaceutical Import Records from India — 6 Products, $13.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Micro Labs Gmbh — Pharmaceutical Importer Profile (2026) | 6 Products, $13.4M Trade | TransData Nexus

Micro Labs Gmbh

Pharmaceutical Importer · Belgium · CNS & Psychiatric Focus · $13.4M Total Trade · DGFT Verified

Micro Labs Gmbh is a pharmaceutical importer based in Belgium with a total trade value of $13.4M across 6 products in 4 therapeutic categories. Based on 311 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Micro Labs Gmbh sources from 1 verified Indian supplier, with Micro Labs Limited accounting for 100.0% of imports.

Micro Labs Gmbh — Import Portfolio & Supplier Network

Micro Labs Gmbh import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Micro Labs Gmbh?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Micro Labs Limited	$33.7M	1,388	100.0%

Micro Labs Gmbh sources from 1 verified Indian supplier across 944 distinct formulations. The sourcing is highly concentrated — Micro Labs Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Micro Labs Gmbh Import?

Formulation	Value	Ships
Gabapentin-micro labs 300 MG	$1.2M	30
Gabapentin-micro labs 100 MG	$612.8K	13
Etoricoxib micro labs 30 MG	$545.7K	14
Diclofenac-natrium micro labs 75 MG	$436.6K	14
Gabapentin-micro labs 600 MG	$411.9K	11
Amitriptylin micro labs 88.38MG	$307.5K	9
Telmisartan micro labs 80 MG tabletten	$300.0K	6
Amitriptylin micro labs 8,84MG	$222.6K	6
Telmisartan micro labs 80 MG	$209.0K	8
Gabapentin-micro labs 400 MG	$206.0K	10
Amoxicillin micro labs 500MG/5ML pfos	$204.0K	10
Etoricoxib micro labs 60 MG	$200.8K	7
Etoricoxib micro labs 90MG	$200.0K	4
Amoxicillin/clavulansaure micro labs 875MG/125MG filmtabletten (co-amoxiclav 875MG/125MG BP Film-Coated tablets)	$200.0K	4
Escitalopram micro labs 10 MG	$199.8K	7

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Gabapentin	CNS & Psychiatric	$7.3M	157	0.9%	18
2	Telmisartan	Cardiovascular	$2.2M	54	0.0%	12
3	Ezetimibe	Lipid & Metabolism	$1.6M	33	0.3%	11
4	Escitalopram	CNS & Psychiatric	$1.3M	49	0.7%	20
5	Vati	Ayurvedic & Herbal Products	$550.0K	11	2.1%	6
6	Enalapril	Cardiovascular	$350.0K	7	0.1%	12

Micro Labs Gmbh imports 6 pharmaceutical products across 4 categories into Belgium totaling $13.4M.

Micro Labs Gmbh — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Micro Labs GmbH is a pharmaceutical importer and distributor based in Belgium, specializing in the procurement and distribution of finished pharmaceutical formulations. The company plays a pivotal role in ensuring the availability of essential medications within the Belgian market, particularly focusing on products sourced from India. By importing a diverse range of pharmaceutical products, Micro Labs GmbH contributes significantly to the healthcare sector, addressing both common and specialized medical needs.

The company's operations are characterized by a strategic focus on therapeutic areas such as Central Nervous System (CNS) and Psychiatric disorders, Cardiovascular diseases, and Lipid & Metabolism disorders. This targeted approach aligns with the prevalent health concerns in Belgium, ensuring that Micro Labs GmbH's product portfolio meets the therapeutic demands of the population. Through its dedicated efforts, the company not only supports the Belgian healthcare system but also strengthens the bilateral trade relations between Belgium and India in the pharmaceutical sector.

2Distribution Network

Micro Labs GmbH's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Belgium. While specific warehouse locations are not publicly disclosed, the company maintains a robust logistics infrastructure capable of handling a diverse range of pharmaceutical formulations. This infrastructure supports the timely and reliable distribution of medications to various healthcare facilities, including hospitals, pharmacies, and clinics throughout the country.

The company's logistics capabilities are further enhanced by its partnerships with established Indian pharmaceutical manufacturers, particularly Micro Labs Limited, which supplies a significant portion of the imported products. This collaboration ensures a steady supply chain, enabling Micro Labs GmbH to meet the demands of the Belgian market effectively. The geographic coverage extends beyond Belgium, facilitating the importation of pharmaceutical products from India to Belgium, thereby contributing to the broader European pharmaceutical supply chain.

3Industry Role

In Belgium's pharmaceutical supply chain, Micro Labs GmbH functions primarily as a wholesaler and distributor. The company imports finished pharmaceutical formulations from India and supplies them to various stakeholders within the Belgian healthcare system, including hospitals, pharmacies, and clinics. By focusing on the importation of finished products, Micro Labs GmbH ensures that these medications are readily available for immediate use, thereby streamlining the supply process and reducing lead times for healthcare providers.

Additionally, Micro Labs GmbH's role extends to parallel importing, where it sources pharmaceutical products from other European Economic Area (EEA) member states to address critical unavailability in Belgium. This practice is in line with the provisions of Article 105/1 of the Royal Decree of 14 December 2006, which allows wholesalers to import medicinal products not authorized in Belgium if they meet a special need due to critical unavailability. By engaging in parallel importing, Micro Labs GmbH contributes to mitigating shortages and ensuring continuous access to essential medications for Belgian patients. (faag.be)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Micro Labs Gmbh

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Micro Labs GmbH's sourcing strategy exhibits a high degree of concentration, with a sole supplier—Micro Labs Limited—accounting for the entirety of its pharmaceutical imports from India. This exclusive partnership has resulted in a total import value of $13.4 million USD over 311 shipments, encompassing 944 unique formulations across six products and four therapeutic categories. The top five imported products include Gabapentin ($7.3M), Telmisartan ($2.2M), Ezetimibe ($1.6M), Escitalopram ($1.3M), and Vati ($550K), collectively representing 97.4% of the total import value.

The decision to maintain a single-source supply chain with Micro Labs Limited may be a strategic choice aimed at ensuring consistency in product quality, pricing, and supply reliability. Such a concentrated sourcing model can lead to favorable terms and streamlined logistics. However, this approach also introduces potential risks, including vulnerability to supply disruptions, price fluctuations, and changes in regulatory compliance. The absence of alternative suppliers means that any issues affecting Micro Labs Limited could directly impact Micro Labs GmbH's ability to meet market demands.

The shipment data indicates a stable relationship between Micro Labs GmbH and Micro Labs Limited, as evidenced by the consistent volume and value of imports over the years. This stability suggests effective collaboration and mutual trust. Nonetheless, the lack of supplier diversification underscores the importance of proactive risk management strategies to mitigate potential disruptions in the supply chain.

2Supply Chain Resilience

Importing Pharmaceuticals into Belgium — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Belgium

1Regulatory Authority & Framework

In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) serves as the primary regulatory authority overseeing the importation, distribution, and marketing of medicinal products. The FAMHP is responsible for ensuring that all pharmaceutical products meet the required standards of quality, safety, and efficacy before they are made available to the Belgian public. The agency operates under the framework of the Royal Decree of 14 December 2006, which outlines the regulations governing medicinal products for human use. (faag.be)

The Royal Decree of 14 December 2006 provides a comprehensive legal framework for the importation and distribution of medicinal products in Belgium. It includes provisions for the marketing authorization of medicinal products, the responsibilities of importers and distributors, and the procedures for addressing issues related to the unavailability of medicines. Notably, Article 105/1 of this decree, effective from 1 November 2024, allows wholesalers to import medicinal products not authorized in Belgium if they meet a special need due to critical unavailability. (faag.be)

2Import Licensing & GMP

Import licensing in Belgium is governed by the FAMHP, which requires importers to obtain the necessary authorizations before bringing medicinal products into the country. This process ensures that all imported pharmaceuticals comply with Belgian regulations and meet the required standards of quality, safety, and efficacy. Additionally, the FAMHP recognizes Good Manufacturing Practice (GMP) certificates from various international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). This recognition facilitates the importation of medicinal products from countries with established GMP standards, such as India. (famhp.be)

Frequently Asked Questions — Micro Labs Gmbh

What products does Micro Labs Gmbh import from India?

Micro Labs Gmbh imports 6 pharmaceutical products across 4 categories. Top imports: Gabapentin ($7.3M), Telmisartan ($2.2M), Ezetimibe ($1.6M), Escitalopram ($1.3M), Vati ($550.0K).

Who supplies pharmaceuticals to Micro Labs Gmbh from India?

Micro Labs Gmbh sources from 1 verified Indian suppliers. The primary supplier is Micro Labs Limited (100.0% of imports, $33.7M).

What is Micro Labs Gmbh's total pharmaceutical import value?

Micro Labs Gmbh's total pharmaceutical import value from India is $13.4M, based on 311 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Micro Labs Gmbh focus on?

Micro Labs Gmbh imports across 4 categories. The largest: CNS & Psychiatric (64.6%), Cardiovascular (19.0%), Lipid & Metabolism (12.3%).

Get Full Micro Labs Gmbh Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Micro Labs Gmbh

Micro Labs Gmbh — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Micro Labs Gmbh?

What Formulations Does Micro Labs Gmbh Import?

What Products Does Micro Labs Gmbh Import?

Top Products by Import Value

Micro Labs Gmbh Therapeutic Categories — 4 Specializations